On Friday, July 31, Merck & Co MRK will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Earnings and Revenue
Analysts expect Merck & Co earnings of $1.04 per share. Revenue will likely be around $10.39 billion, according to the consensus estimate. Merck & Co reported a per-share profit of $1.30 when it published results during the same quarter last year. Sales in that period totaled $11.76 billion. The Wall Street estimate would represent a 20.0% decline in the company's earnings. Revenue would be down 9.34% from the year-ago period. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | 1.34 | 1.15 | 1.24 | 1.16 |
| EPS Actual | 1.50 | 1.16 | 1.51 | 1.30 |
| Revenue Estimate | 11.46 B | 11.98 B | 11.63 B | 10.96 B |
| Revenue Actual | 12.06 B | 11.87 B | 12.40 B | 11.76 B |
Stock Performance
Shares of Merck & Co were trading at $79.34 as of July 31. Over the last 52-week period, shares are down 6.82%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Merck & Co is scheduled to hold the call at 08:00:00 ET and can be accessed here: https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI:4;F:QS!10100&ShowUUID=0A98C37B-4869-4FDF-927E-F53E6E27E50C&LangLocaleID=1033&Referrer=https%3A%2F%2Finvestors.merck.com%2Fhome%2Fdefault.aspx
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
